Department of Cardiac Thoracic Vascilar Sciences and Public Health, Unit of Occupational Medicine, University of Padova, Padova, Italy.
Department of Cardiac Thoracic Vascilar Sciences and Public Health, Unit of Occupational Medicine, University of Padova, Padova, Italy.
Int J Infect Dis. 2020 Jul;96:228-232. doi: 10.1016/j.ijid.2020.04.082. Epub 2020 May 5.
The goal of this study was to establish the seroprevalence of positive antibodies against varicella and compliance with varicella vaccination in the pre-vaccination era.
A cohort of 10 683 Italian students from Padua University Medical School (from 2004 to 2019) were enrolled and classified as unvaccinated, vaccinated once, or vaccinated twice against varicella, according to their vaccination certificate. The antibody titre was measured and the seroprevalence of positive subjects was determined. Subjects with negative or equivocal antibodies were invited for vaccination, and then the antibody titre was retested.
Unvaccinated students were mostly seropositive (95.6%), compared with vaccinated students who were less seropositive (68.0% after one dose and 78.6% after two doses) and had significantly lower antibody titres (p < 0.0001). The post-test vaccination had a positive response rate of 85.4%: 67.4% after one dose and 91.4% after two doses.
In the pre-vaccination era, only 3.3% of future healthcare workers were vaccinated against varicella (1.1% once and 2.2% twice). Vaccination or revaccination of negative and equivocal individuals could reduce the number of susceptible people. Implementation of varicella vaccine (two doses) in healthcare workers is of primary importance to reduce the risk of transmission.
本研究旨在确定接种疫苗前水痘抗体阳性率及水痘疫苗接种的依从性。
本研究纳入了来自帕多瓦大学医学院的 10683 名意大利学生(2004 年至 2019 年),根据他们的疫苗接种证书,将他们分为未接种、接种过一次或接种过两次水痘疫苗的人群。测量了抗体滴度,并确定了阳性受试者的血清阳性率。对抗体阴性或可疑的受试者进行了接种邀请,然后再次检测抗体滴度。
未接种疫苗的学生大多数为血清阳性(95.6%),而接种过疫苗的学生则为血清阳性率较低(一剂后为 68.0%,两剂后为 78.6%),且抗体滴度显著较低(p<0.0001)。接种后疫苗的阳性反应率为 85.4%:一剂后为 67.4%,两剂后为 91.4%。
在接种疫苗前的时代,只有 3.3%的未来医护人员接种了水痘疫苗(1.1%接种一剂,2.2%接种两剂)。对阴性和可疑个体进行接种或补种可以减少易感人群的数量。在医护人员中实施水痘疫苗(两剂)接种对于降低传播风险至关重要。